Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Experimental and Clinical Models of CRH-lnduced Pituitary Tumors — Michael Karl (2015) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Experimental and Clinical Models of CRH-lnduced Pituitary Tumors
Shared by
George Chrousos
National Technical University of Athens
Experimental and Clinical Models of CRH-lnduced Pituitary Tumors
Chapter In A Book
2015
en
Related publications
Article
2002
Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists
Dimitris K. Grammatopoulos
,
George Chrousos
Article
1996
In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.
Elizabeth Webster
,
David B. Lewis
,
Authors
MK
Michael Karl
George Chrousos
National And Kapodistrian University Of Athens
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
David J. Torpy
,
E. Keith Zachman
,
Kenner C. Rice
,
George Chrousos
Article
2021
Hypothalamic–pituitary–adrenal (HPA) axis response to exogenous corticotropin‐releasing hormone (CRH) is attenuated in men with chronic insomnia
Alexandros N. Vgontzas
,
Julio Fernández‐Mendoza
,
Kristina Lenker
,
Maria Basta
,
Edward O. Bixler
,
George Chrousos
Article
1987
Pharmacology of ovine and human CRH.
Thomas H. Schürmeyer
,
H M Schulte
,
Peter C. Avgerinos
,
Thomas P. Tomai
,
D. Lynn Loriaux
,
P W Gold
,
George Chrousos
Article
1987
Pharmacology of ovine and human CRH.
Thomas H. Schürmeyer
,
H M Schulte
,
Peter C. Avgerinos
,
Thomas P. Tomai
,
D. Lynn Loriaux
,
P W Gold
,
George Chrousos
Discussion(0)
No comments yet. Be the first to comment.